Pd50-06 Long-Term Safety and Tolerability of Oral Testosterone (Lpcn 1021) in Hypogonadal Men: Results From the 52-Week Phase 3 Study
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.2796
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)